A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

Bristol-Myers Squibb297 enrolled

Overview

A medical review chart study in Japan to describe the treatment patterns and outcomes of patients with kidney cancer that is unable to be removed by surgery or that has spread. The clinical data is to be abstracted using electronic data capture (eDC) from patient medical records in Japan.

Study Type

OBSERVATIONAL

Enrollment

297

Conditions

Renal Cell Carcinoma

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Adults 20 years and older at the time of initial diagnosis of mRCC * Alive or deceased as of the date of data collection * Diagnosis of mRCC between 01-Jan-2012 and 31-Aug-2015 Exclusion Criteria: * Previously and/or currently enrolled in RCC clinical trials * Patients have primary cancer other than renal cell cancer

Locations (1)

Local Institution

Tokyo, Japan

Outcomes

Primary Outcomes

Treatment patterns

measured by retrospective data collection of treatment regimen and duration (including rate of permanent and temporary discontinuation)

Time frame: Approximately 5 years

Overall survival

measured by data collection in years

Time frame: Approximately 2 years

Reason for terminating or switching treatment

measured by data collection information available in retrospective analysis, if disclosed

Time frame: Approximately 5 years

Adverse Events

measured by data collection

Time frame: Approximately 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.